Therefore, preventive or reactive treatment of skin rash caused by EGFR-TKI which improves the treatment compliance is essential to the patients with pancreatic cancer under EGFR-TKI treatment. The gene discussed is EGFR; the disease is familial pancreatic carcinoma.